An accurate prediction of response to radiotherapy would allow treatme
nts to be modified for those individuals where a relatively poor respo
nse is expected with conventional treatment. Present assays receiving
most attention are those for repopulation, radiosensitivity and hypoxi
a. This paper discusses our experience with the first two, together wi
th relevant data from other groups. Attention is focussed particularly
on correlations with outcome in clinical trials, and the accuracy of
present assay methods.